Professional article
OA Policy
French

Hormonal treatments and venous thrombosis in women

Published in

Revue médicale suisse, vol. 13, no. 580, p. 1821-1825

Publication date

2017

Abstract

Venous thromboembolism is frequently associated with hormonal factors in women. A thorough medical history taking of vascular risks and an individual evaluation of the risk-benefit ratio should precede any prescription of hormonal therapies. In contrary to progestin-only-pills, estroprogestative contraceptives increase 3-6 times the risk of venous thrombosis. In assisted reproductive techniques, venous thrombosis is frequently associated with the occurrence of a severe ovarian hyperstimulation syndrome. Antagonist ovarian stimulation protocols lower the risk of hyperstimulation and should therefore be preferred. Finally, at menopause, hormonal treatments combining transdermal estradiol and micronized progesterone do not seem to increment the risk of thrombosis.

Citation (ISO format)

HUGON-RODIN, Justine et al. Hormonal treatments and venous thrombosis in women. In: Revue médicale suisse, 2017, vol. 13, n° 580, p. 1821–1825.

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1660-9379
424views
197downloads

Technical informations

Creation

13/11/2018 10:45:00

First validation

13/11/2018 10:45:00

Update

14/03/2025 14:59:30

Status update

14/03/2025 14:59:30

Last indexation

14/03/2025 14:59:32
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated